Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.

Waites KB, Duffy LB, Bébéar CM, Matlow A, Talkington DF, Kenny GE, Totten PA, Bade DJ, Zheng X, Davidson MK, Shortridge VD, Watts JL, Brown SD.

J Clin Microbiol. 2012 Nov;50(11):3542-7. doi: 10.1128/JCM.01439-12. Epub 2012 Aug 22.

2.

Direct testing of bronchoalveolar lavages from ventilator-associated pneumonia patients.

Boyer A, Medrano J, Mzali F, Balick-Weber CC, Bessède E, Picard W, Clouzeau B, Bébéar CM, Vargas F, Hilbert G, Rogues AM, Gruson D.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):107-10. doi: 10.1016/j.diagmicrobio.2012.02.017. Epub 2012 Apr 5.

PMID:
22483191
3.

Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing.

Harris SR, Clarke IN, Seth-Smith HM, Solomon AW, Cutcliffe LT, Marsh P, Skilton RJ, Holland MJ, Mabey D, Peeling RW, Lewis DA, Spratt BG, Unemo M, Persson K, Bjartling C, Brunham R, de Vries HJ, Morré SA, Speksnijder A, Bébéar CM, Clerc M, de Barbeyrac B, Parkhill J, Thomson NR.

Nat Genet. 2012 Mar 11;44(4):413-9, S1. doi: 10.1038/ng.2214.

4.

Effects of antibiotics on Chlamydia trachomatis viability as determined by real-time quantitative PCR.

Peuchant O, Duvert JP, Clerc M, Raherison S, Bébéar C, Bébéar CM, de Barbeyrac B.

J Med Microbiol. 2011 Apr;60(Pt 4):508-14. doi: 10.1099/jmm.0.023887-0. Epub 2010 Dec 23.

PMID:
21183597
5.

Detection and susceptibility testing of Mycoplasma amphoriforme isolates from patients with respiratory tract infections.

Pereyre S, Renaudin H, Touati A, Charron A, Peuchant O, Hassen AB, Bébéar C, Bébéar CM.

Clin Microbiol Infect. 2010 Jul;16(7):1007-9. doi: 10.1111/j.1469-0691.2009.02993.x. Epub 2009 Jul 15.

6.

Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S.

J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.

PMID:
19429926
7.

Evaluation of five commercial real-time PCR assays for detection of Mycoplasma pneumoniae in respiratory tract specimens.

Touati A, Benard A, Hassen AB, Bébéar CM, Pereyre S.

J Clin Microbiol. 2009 Jul;47(7):2269-71. doi: 10.1128/JCM.00326-09. Epub 2009 Apr 29.

8.

Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae.

Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar CM.

J Clin Microbiol. 2009 Apr;47(4):914-23. doi: 10.1128/JCM.01935-08. Epub 2009 Feb 9.

9.

Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.

Bébéar CM, de Barbeyrac B, Pereyre S, Renaudin H, Clerc M, Bébéar C.

Clin Microbiol Infect. 2008 Aug;14(8):801-5. doi: 10.1111/j.1469-0691.2008.02027.x.

10.

Urogenital mycoplasma: an emerging cause of deep wound infection after kidney transplantation?

Loupy A, Join-Lambert OF, Bébéar CM, Legendre C, Anglicheau D.

NDT Plus. 2008 Aug;1(4):239-40. doi: 10.1093/ndtplus/sfn053. Epub 2008 May 25. No abstract available.

11.

[Pathogenesis and laboratory diagnosis of Mycoplasma pneumoniae infections].

Bébéar CM.

Arch Pediatr. 2008 Jul;15(7):1253-6. doi: 10.1016/j.arcped.2008.02.010. Epub 2008 Apr 11. French.

PMID:
18406582
12.

Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae.

Dégrange S, Renaudin H, Charron A, Pereyre S, Bébéar C, Bébéar CM.

J Antimicrob Chemother. 2008 Jun;61(6):1390-2. doi: 10.1093/jac/dkn118. Epub 2008 Mar 19. No abstract available.

PMID:
18356155
13.
14.
15.

Contribution of tap water to patient colonisation with Pseudomonas aeruginosa in a medical intensive care unit.

Rogues AM, Boulestreau H, Lashéras A, Boyer A, Gruson D, Merle C, Castaing Y, Bébear CM, Gachie JP.

J Hosp Infect. 2007 Sep;67(1):72-8. Epub 2007 Aug 28.

PMID:
17728016
16.

Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.

Pereyre S, Métifiot M, Cazanave C, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Int J Antimicrob Agents. 2007 Feb;29(2):207-11. Epub 2006 Dec 28.

PMID:
17196370
17.

Candida albicans outbreak in a neurosurgical intensive care unit.

Lasheras A, Rogues AM, Peyrere S, Boulard G, Bebear CM, Gachie JP, Bretagne S, Dromer F.

J Hosp Infect. 2007 Feb;65(2):181-2. Epub 2006 Dec 14. No abstract available.

PMID:
17174008
18.

[Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections].

de Barbeyrac B, Obeniche F, Ratsima E, Labrouche S, Moraté C, Renaudin H, Pereyre S, Bébéar CM, Bébéar C.

Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):409-19. Review. French.

19.

[Clinical, microbiological, and therapeutic aspects of Nocardia sp. infections in the Bordeaux hospital from 1993 to 2003].

Moiton MP, Robert D, Bébéar CM, Neau D, Dugué C, Ragnaud JM.

Med Mal Infect. 2006 May;36(5):264-9. Epub 2006 Jun 9. French.

PMID:
16762519
20.

Transnasal puncture based on echographic sinusitis evidence in mechanically ventilated patients with suspicion of nosocomial maxillary sinusitis.

Vargas F, Bui HN, Boyer A, Bébear CM, Lacher-Fougére S, De-Barbeyrac BM, Salmi LR, Traissac L, Gbikpi-Benissan G, Gruson D, Hilbert G.

Intensive Care Med. 2006 Jun;32(6):858-66. Epub 2006 Apr 14.

PMID:
16614810
21.

Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.

Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM.

J Antimicrob Chemother. 2006 Apr;57(4):753-6. Epub 2006 Feb 7.

PMID:
16464889
22.

Mechanisms of drug resistance in Mycoplasma pneumoniae.

Bébéar CM, Pereyre S.

Curr Drug Targets Infect Disord. 2005 Sep;5(3):263-71. Review.

PMID:
16181145
23.

In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.

Gruson D, Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2005 Mar;49(3):1190-3.

24.

Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis.

Raherison S, Gonzalez P, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2005 Jan;49(1):421-4.

25.

In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.

Pereyre S, Renaudin H, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2004 Aug;48(8):3165-8.

26.

In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.

Pereyre S, Guyot C, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2004 Feb;48(2):460-5.

27.

Mitochondrial activities in human cultured skin fibroblasts contaminated by Mycoplasma hyorhinis.

Darin N, Kadhom N, Brière JJ, Chretien D, Bébéar CM, Rötig A, Munnich A, Rustin P.

BMC Biochem. 2003 Nov 4;4:15.

28.

DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.

Bébéar CM, Renaudin H, Charron A, Clerc M, Pereyre S, Bébéar C.

Antimicrob Agents Chemother. 2003 Oct;47(10):3323-5.

29.

Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.

Gruson D, Hilbert G, Vargas F, Valentino R, Bui N, Pereyre S, Bebear C, Bebear CM, Gbikpi-Benissan G.

Crit Care Med. 2003 Jul;31(7):1908-14.

PMID:
12847382
30.

Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.

Pereyre S, Gonzalez P, De Barbeyrac B, Darnige A, Renaudin H, Charron A, Raherison S, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2002 Oct;46(10):3142-50.

31.

Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations.

Morrissey I, Salman H, Bakker S, Farrell D, Bébéar CM, Ridgway G.

J Antimicrob Chemother. 2002 May;49(5):757-61.

PMID:
12003968
32.

Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Raherison S, Gonzalez P, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2002 Mar;46(3):672-9.

33.

Characterization of mutations in DNA gyrase and topoisomerase IV Involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro.

Reinhardt AK, Bébéar CM, Kobisch M, Kempf I, Gautier-Bouchardon AV.

Antimicrob Agents Chemother. 2002 Feb;46(2):590-3.

34.

Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens.

Hammerschlag MR, Roblin PM, Bébéar CM.

J Antimicrob Chemother. 2001 Sep;48 Suppl T1:25-31. Review.

PMID:
11566973
35.

Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium.

Dhandayuthapani S, Blaylock MW, Bebear CM, Rasmussen WG, Baseman JB.

J Bacteriol. 2001 Oct;183(19):5645-50.

36.

Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency virus-infected patient.

Niobe SN, Bebear CM, Clerc M, Pellegrin JL, Bebear C, Maugein J.

J Clin Microbiol. 2001 May;39(5):2030-2.

37.

In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.

Pereyre S, de Barbeyrac B, Renaudin H, Poutiers F, Bébéar C, Bébéar CM.

J Antimicrob Chemother. 2001 Feb;47(2):240-1. No abstract available.

PMID:
11157917
38.
40.

[Biological diagnosis of infections caused by mycoplasmas].

Bébéar C, Pereyre S, Bébéar CM.

Arch Pediatr. 2000 May;7 Suppl 2:311s-313s. French. No abstract available.

PMID:
10904755
41.

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas.

Bebear CM, Renaudin H, Bryskier A, Bebear C.

Antimicrob Agents Chemother. 2000 Jul;44(7):1980-2.

42.

Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics.

Lelièvre H, Lina G, Jones ME, Olive C, Forey F, Roussel-Delvallez M, Nicolas-Chanoine MH, Bébéar CM, Jarlier V, Andremont A, Vandenesch F, Etienne J.

J Clin Microbiol. 1999 Nov;37(11):3452-7.

43.

In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.

Bébéar CM, Renaudin H, Schaeverbeke T, Leblanc F, Bébéar C.

J Antimicrob Chemother. 1999 May;43(5):711-4.

PMID:
10382895
44.

Severe respiratory failure requiring ICU admission in bone marrow transplant recipients.

Gruson D, Hilbert G, Portel L, Boiron JM, Bebear CM, Vargas F, Bebear C, Reiffers J, Gbikpi-Benissan G, Cardinaud JP.

Eur Respir J. 1999 Apr;13(4):883-7.

45.

Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

Bebear CM, Renaudin J, Charron A, Renaudin H, de Barbeyrac B, Schaeverbeke T, Bebear C.

Antimicrob Agents Chemother. 1999 Apr;43(4):954-6.

46.

Characteristics of arthritogenic bacteria. The bacteriologist's point of view.

Bébéar CM, Schaeverbeke T, Bébéar C.

Rev Rhum Engl Ed. 1999 Jan 30;66(1 Suppl):57S-59S. Review. No abstract available.

PMID:
10063527
47.

What is the role of mycoplasmas in human inflammatory rheumatic disorders?

Schaeverbeke T, Bébéar CM, Clerc M, Lequen L, Bébéar C, Dehais J.

Rev Rhum Engl Ed. 1999 Jan 30;66(1 Suppl):23S-27S. Review. No abstract available.

PMID:
10063520
48.

Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis.

Schaeverbeke T, Lequen L, de Barbeyrac B, Labbé L, Bébéar CM, Morrier Y, Bannwarth B, Bébéar C, Dehais J.

Arthritis Rheum. 1998 Oct;41(10):1889-93.

PMID:
9778232
49.
50.

Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro.

Bébéar CM, Renaudin H, Charron A, Bové JM, Bébéar C, Renaudin J.

Antimicrob Agents Chemother. 1998 Sep;42(9):2304-11.

Supplemental Content

Loading ...
Support Center